Cargando…
2765. Dalbavancin for challenging left ventricular assist device driveline infections
BACKGROUND: Driveline tract and exit site infections (DLI) in patients on left ventricular assist device (LVAD) support occur frequently and are associated with significant morbidity, mortality and recurrence. Dalbavancin is a gram+ active lipoglycopeptide antibiotic with a prolonged half-life. Give...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676933/ http://dx.doi.org/10.1093/ofid/ofad500.2376 |